Bacterial biofilm formation during chronic infections confers increased fitness, antibiotic tolerance, and cytotoxicity. In many pathogens, the transition from a planktonic lifestyle to collaborative, sessile biofilms represents a regulated process orchestrated by the intracellular second-messenger c-di-GMP. A main effector for c-di-GMP signaling in the opportunistic pathogen Pseudomonas aeruginosa is the transcription regulator FleQ. FleQ is a bacterial enhancer-binding protein (bEBP) with a central AAA+ ATPase σ 54 -interaction domain, flanked by a C-terminal helix-turn-helix DNA-binding motif and a divergent N-terminal receiver domain. Together with a second ATPase, FleN, FleQ regulates the expression of flagellar and exopolysaccharide biosynthesis genes in response to cellular c-di-GMP. Here we report structural and functional data that reveal an unexpected mode of c-di-GMP recognition that is associated with major conformational rearrangements in FleQ. Crystal structures of FleQ's AAA+ ATPase domain in its apo-state or bound to ADP or ATP-γ-S show conformations reminiscent of the activated ring-shaped assemblies of other bEBPs. As revealed by the structure of c-di-GMP-complexed FleQ, the second messenger interacts with the AAA+ ATPase domain at a site distinct from the ATP binding pocket. c-di-GMP interaction leads to active site obstruction, hexameric ring destabilization, and discrete quaternary structure transitions. Solution and cell-based studies confirm coupling of the ATPase active site and c-di-GMP binding, as well as the functional significance of crystallographic interprotomer interfaces. Taken together, our data offer unprecedented insight into conserved regulatory mechanisms of gene expression under direct c-di-GMP control via FleQ and FleQ-like bEBPs.
B acterial adaptations to diverse environments, including human hosts, involve collaborative group behaviors, such as quorum sensing, swarming, and biofilm formation (1) (2) (3) (4) (5) . In general, quorum-sensing during host tissue colonization is associated with virulence gene expression and acute-phase infections, whereas biofilm formation facilitates the development of chronic infections, evasion of host immune response, and increased tolerance to treatments (6) . It is now well appreciated that these social behaviors result from highly regulated signal transduction processes, which in many bacteria are choreographed by the nucleotide-based second messenger c-di-GMP (7) (8) (9) . Synthesized by GGDEF domain-containing diguanylate cyclases and hydrolyzed by EAL or HD-GYP domain-containing phosphodiesterases, c-di-GMP is sensed by a variety of protein-and RNA-based effectors to exert control at transcriptional, translational, and posttranslational levels (10, 11) .
In Pseudomonas aeruginosa, an opportunistic pathogen that causes severe chronic infections in cystic fibrosis patients, burn victims, and other immunocompromised individuals, the transcription factor FleQ acts as a master regulator of flagellar motility and exopolysaccharide (EPS) secretion to mediate the transition between planktonic and biofilm lifestyles (12) (13) (14) . (Fig. 1A) . FleQ shares significant homology and similarities in gene-expression regulation with members of the NtrC subfamily of bacterial enhancer binding proteins (bEBPs) (15) .
Typically, bEBP with REC domains are regulated by phosphorylation via cognate histidine kinases, whereby transfer of a phosphoryl group from the kinase to the REC domain alters molecular interactions within or between bEBPs (16, 17) . As a result, phosphorylated bEBPs, reorganized into ring-shape hexamers, bind ∼150 bp upstream of the transcription start site, recruit the σ 54 -RNAP-promoter complex, and initiate transcription in an ATPase-dependent manner (18) (19) (20) . Despite similar domain architecture, however, FleQ appears to use a drastically different mechanism of regulation (13, 14, 21) . FleQ
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Pseudomonas aeruginosa, an opportunistic pathogen that can cause fatal chronic infections, relies on the intracellular secondmessenger c-di-GMP to form robust multicellular biofilms during host tissue colonization. c-di-GMP is sensed directly by the transcription regulator FleQ, which inversely regulates flagellar motility and exopolysaccharide secretion to secure a planktonic to sessile life-form transition. FleQ belongs to the diverse family of AAA+ ATPase enhancer-binding proteins, but how its noncanonical function on transcriptional regulation is controlled by c-di-GMP remains enigmatic. Here, we report structural and functional data that identify an unusual mode of c-di-GMP recognition accompanied by a major quaternary structure reorganization. Our analyses offer a consensus to previous studies and unique insights into the mechanism of action of FleQ and FleQ-like proteins.
lacks both a cognate sensor kinase and conserved REC domain residues that are crucial for phosphotransfer and phosphorylation-dependent conformational changes. Instead of relying on covalent modifications, its function depends on direct proteinprotein interactions with FleN, a distinct ATPase that acts largely as a FleQ antagonist (22) . Furthermore, at promoters of the flagellar biosynthesis gene cluster, FleQ not only binds to enhancer sequences upstream of the transcription start site-like classic bEBPs-but also at sites downstream from the transcription start sites (13, 23) . In addition, and most relevant for this study, c-di-GMP directly binds to and regulates FleQ, altering target promoter activity (13, 14, 21) .
C-di-GMP exerts distinct effects on FleQ's regulatory roles at the flagellar and EPS biosynthesis operons, underscoring the system's multifaceted role in biofilm formation (21) . The dinucleotide dampens FleQ's ATPase activity and causes a modest but significant down-regulation of flagellar gene expression (13, 14, 21) . In contrast, FleQ acts as a repressor of Pel EPS expression in the absence of c-di-GMP. An increase of intracellular c-di-GMP levels through the action of diguanylate cyclases not only relieves FleQ-mediated gene repression, but it converts the protein into a potent transcription activator (13) . Strikingly, gene expression activation under these conditions does not appear to require FleQ's intrinsic ATPase activity, is σ
54
-independent, and likely proceeds through σ 70 (21, 24) . On both flagellar and pel promoters FleN further modulates FleQ-mediated gene regulation (14, 21) . However, FleN's effect on the regulation of flagella expression and assembly is much more pronounced, with deletion of P. aeruginosa fleN leading to multiflagellated cells and only a small down-regulation in pel expression (14, 25) .
How FleQ is able to exert such different effects and to sense different regulatory inputs at its target promoters has so far remained enigmatic. With regard to c-di-GMP signal recognition, at least two distinct modes of second-messenger binding in the context of FleQ's tertiary structure have been proposed (21, 26) . It is unclear, however, how c-di-GMP recognition would affect the various aspects of the protein's higher-order regulatory mechanics. Here we present crystallographic data and solutionbased structure-function analyses that reveal an unexpected mode of c-di-GMP regulation. In particular, we show that binding of the second messenger occurs at a composite site within the FleQ AAA+ domain and is accompanied by a major quaternary structure reorganization and allosteric ATPase inhibition. Our results reconcile previous modeling and functional studies (13, 14, 21, 26) , and provide an integrated model for FleQ-dependent transcription regulation of genes involved in EPS production and secretion.
Results

Canonical, Ring-Shaped FleQ Hexamers Revealed by Crystal Structures of
Its AAA+ Domain. The AAA+ ATPase domain of bEBPs couples ATP binding and hydrolysis to transcription complex remodeling (18) . All bEBPs' functional features, including the specific σ 54 -interaction loops-L1, which contains the signature GAFTGA motif (27) , and L2-are conserved in FleQ (Fig. 1A) . Purified, nucleotide-free Pa_FleQ AAA (residues 137-394) crystallized in space group P6 5 and its structure was determined to 1.8 Å resolution by single-wavelength anomalous dispersion (SAD) phasing on iodidederivatized crystals. Using the apo-structure as the search model, structures of Pa_FleQ AAA cocrystallized with ADP or ATP-γ-S were solved by molecular replacement and refined to a resolution of 2.4 Å and 2.5 Å, respectively (Table S1 ). In these structures, Pa_FleQ AAA adopts a canonical bilobal fold comprising a larger N-terminal α/β subdomain typical for P-loop NTPases (SD1) and an α-helical subdomain specific for AAA+ ATPases (SD2) (Fig.  1B) (20, 28) . Apart from subtle changes caused by nucleotide coordination, the apo-and nucleotide-bound structures are virtually identical, with an all-atom rmsd lower than 0.6 Å in pairwise superpositions of protomers. Both ADP and ATP-γ-S interact with residues S 176 and K 180 from Walker A (G 174 xxGxGKE), as well as with a conserved R 363 from the so-called sensor II motif in subdomain SD2 (Fig. 1C and Fig. S1D ) (28) . Ribose sugar moieties are additionally coordinated by the SD2 residue R
334
. In the ATP-γ-S-bound form, the γ-phosphate of the nucleotide is sensed by D 245 and, indirectly, by E 246 from the Walker B motif (T 241 LFLDE) (Fig. 1C and Fig. S1A ). Although the asymmetric units of all three structures contain a single polypeptide chain, a view along the sixfold symmetry axes reveals protomer packing similar to the hexameric rings of activated canonical AAA+ proteins (Fig. 1D) (28) . Rather than forming discrete oligomers, however, the protomers arrange in continuous spirals along the screw axes (Fig. 1D, Right) . Interestingly, similar spiral arrangements are observed in the crystal packing of the isolated AAA+ domain of Escherichia coli PspF (Ec_PspF AAA ), a bEBP known to form discrete hexameric rings in solution (29) . PspF ring oligomers are believed to undergo sequential hydrolysis where asymmetry in the intersubunit interactions confers cooperativity in nucleotide binding and catalysis (30) . In addition, solution structural studies on ring hexamers of another nonhelical bEBP, NtrC1, revealed that one of the intersubunit interfaces is significantly less tight, which led to a mechanistic model where bEBP planar ring split is necessary to drive interactions with the σ 54 -RNAP holoenzyme and ATPdependent remodeling (31) .
Because the formation of ring-shaped FleQ assemblies would only require subtle changes in the protomer-packing interfaces observed in the crystalline spirals, we continued by examining the actual oligomerization states of FleQ in solution. To this end, we visualized full-length FleQ (Pa_FleQ Full ) by negative-stain electron microscopy following gel filtration in the presence of the transition-state analog ADP-vanadate. Single-particle analysis of the micrographs failed to reveal any filamentous structures but showed discrete hexameric species that are consistent with canonical bEBP ring assembly rather than helical organization (Fig. S1B ). Although these experiments were performed under saturating conditions of a single, nonhydrolyzable nucleotide species and more studies are necessary to examine potential conformational changes and asymmetry along the hydrolytic cycle, it is possible that the crystal packing of the isolated AAA+ domain from both Pa_FleQ and Ec_PspF in the form of open oligomers reflects a conserved mechanism for bEBP activation and function.
Molecular Determinants for c-di-GMP Recognition by FleQ's AAA+ Domain. In the presence of c-di-GMP, a purified AAA-HTH dual domain construct of P. aeruginosa FleQ (Pa_FleQ AAA-HTH , residues 137-477) crystallized in space group P6 3 22 with a single protomer per asymmetric unit. Although the crystals were characterized by extremely high solvent content (∼80%) and suboptimal anisotropic diffraction, the structure was determined by Se-SAD to 3.3 Å resolution with good refinement statistics ( Table  S1 ). The refined electron density map covers residues 138-393 and excludes the C-terminal HTH domain, likely because of flexibility in the loosely packed crystals and insignificant contribution to the X-ray diffraction data.
Two molecules of c-di-GMP bind in their preferred intercalated dimer conformation in a region between subdomains SD1 and SD2 that is different from the ATP-binding active site ( Fig. 2A and Fig. S1A ). An earlier modeling study on a FleQ homolog from Vibrio cholerae, FlrA, suggested that residues corresponding to R 144 and R 185 of P. aeruginosa FleQ constitute a conserved c-di-GMP binding site at the REC and AAA+ domain interface (26) , which was recently confirmed by another modeling-based study (32) . The Pa_FleQ AAA-HTH -c-di-GMP cocrystal structure not only confirms the importance of these residues for c-di-GMP recognition, but also reveals a composite binding site with contributions from three key motifs within a single FleQ protomer ( Fig. 2A) . Cis-acting residues include: a proximal c-di-GMP-binding switch located at the N-terminus of the AAA+ domain that is composed of the LFR 144 S motif (R-switch); residues R 185 and N 186 in helix α7 of subdomain SD1 (post-Walker A); and finally, a distal c-di-GMP-binding motif comprising the ExxxR 334 sequence in helix α13 of subdomain SD2 ( Fig. 2 A and B) . Isothermal titration calorimetry confirms both the stoichiometry of binding (∼2:1 for c-di-GMP:Pa_FleQ
Full with an apparent affinity constant K d of ∼4.1 μM) and the role of conserved arginine residues in ligand coordination ( Fig. S2 A and B) .
A systematic sequence analysis of bEBPs revealed a higher degree of conservation of c-di-GMP binding motifs (R-switch, post-Walker A and ExxxR consensus motifs) within FleQ homologs (Fig. 2B ). This group includes the c-di-GMP-responsive regulator FlrA from V. cholerae, for which the importance of R 135 and R 176 (corresponding to FleQ R 144 and R
185
, respectively) for c-di-GMP binding has been determined experimentally (26) . In particular, the coconservation of all three c-di-GMP-binding motifs, and especially their arginine residues, is striking (Fig. 2B) . Consistent with this notion, isothermal titration calorimetry (ITC) experiments with a FleQ homolog from Xanthomonas citri (XAC1967), which contains divergent c-di-GMP binding motifs (Fig. 2B) , failed to show c-di-GMP binding (Fig. S2C) . On the other hand, co-occurring arginine residues important for c-di-GMP binding were found in several bEBPs with different N-terminal regulatory domains (Fig. 2B , Table 1 , Fig. S3 , and Table  S2 ). Of 4,632 bEBPs mined from a representative proteome database (33) , ∼3% presented conserved c-di-GMP binding residues, suggesting that c-di-GMP regulation of bEBP-mediated transcription may be more widely used than previously anticipated, potentially participating in other cellular processes beyond flagellar regulation and EPS secretion (Fig. 2B and Table 1 ). Additionally, the absence of the aforementioned conserved c-di-GMP binding motifs in the atypical bEBP VpsR from V. cholerae (34) and in AAA+ ATPases involved in multiple bacterial secretion systems (35) , all shown to bind to c-di-GMP, further suggest that bacterial AAA+ domains may represent ubiquitous targets for c-di-GMP, yet with distinct binding sites.
Consequences of c-di-GMP Binding on FleQ's Tertiary and Quaternary
Structure. Compared with apo, ADP-, and ATP-γ-S-bound Pa_FleQ AAA structures, the conformation of the c-di-GMPbound AAA+ ATPase σ 54 -interaction domain reveals novel and unexpected features at both the tertiary and quaternary structure levels. Protomer superposition using subdomain SD1 as the reference reveals a 9°rigid body movement of subdomain SD2 to a more compact, c-di-GMP-stabilized conformation relative to the apo-, ADP-, and ATP-γ-S-bound structures (Fig. 2C) . It has been proposed previously that c-di-GMP competes with ATP for binding to the AAA+ ATPase domain active site based on the fact that c-di-GMP competitively inhibits ATP hydrolysis and that a Walker A disruptive mutation (FleQ K 180 A) abolishes c-di-GMP binding to FleQ (21) . However, this model is at first sight inconsistent with the crystallographic analysis. Superposition of the c-di-GMP-and ATP-γ-S-bound Pa_FleQ AAA structures reconciles the apparent contradictions by revealing that c-di-GMP binding shifts the N terminus of the AAA+ domain into the ATP-binding pocket (Fig. 2D) , thus acting as an allosteric inhibitor of the protein's hydrolytic activity and, by extension, of σ 54 -dependent transcription activation. Importantly, in the context of the full-length protein, such an N-terminal movement in the FleQ AAA+ domain would cause a drastic repositioning of the preceding FleQ REC module, possibly contributing to the disruption of the active-state hexameric ring (Fig. S1C) . Finally, residue K 180 in the Walker A motif occupies a pivotal location between the two AAA+ subdomains and plays a significant role in stabilizing interprotomer interaction within Pa_FleQ AAA hexameric rings (Fig. S1D) . A mutation in this position could interfere with both c-di-GMPmediated AAA+ interdomain movement and oligomeric assembly.
The structural organization of the c-di-GMP binding pocket provides further evidence for negative coupling of this site with the ATPase active site. The highly conserved residues R 144 , R 185 , and R 334 are not only directly involved in c-di-GMP coordination ( Fig. 2A and Fig. S2 ), but also directly or indirectly stabilize ATP binding, as observed in the ADP and ATP-γ-S-complexed Pa_FleQ AAA crystal structures (Fig. 1C) . In particular, residue R 334 is in direct contact with the ribose moiety of ATP, while also stabilizing the N-terminal AAA+ domain segment through π-stacking interactions with R 144 (Fig. 1C) . Similarly, residue R 185 forms a salt bridge with the Walker A residue E 181 , and might also sense nucleotide binding (Fig. 1C ). All these specific interactions important for ATP binding and hydrolysis are disrupted in the c-di-GMPbound state.
The most striking feature of the c-di-GMP-bound structure, however, is the profound reorganization of crystallographic interfaces, which suggests dramatic quaternary structure reorganization upon allosteric second-messenger recognition. The observed c-di-GMP-mediated subdomain movement and N-terminal restructuring appear incompatible with the maintenance of canonical bEBP ring hexamers. Indeed, symmetry-related protomers arrange into a distinct hexameric species where c-di-GMPstabilized trimers dimerize in a head-to-head fashion ("dimerof-trimers") (Fig. 2E ). Dissociation energy analyses of proteinprotein and c-di-GMP-protein interfaces (SD1/SD2, SD2/SD2, and c-di-GMP-mediated interfaces) suggest biological relevance for this unique oligomeric arrangement (Fig. 2F) (36) . Within the trimeric assembly mediated by c-di-GMP, a total buried surface area of about 1,400 Å 2 yields a gain of −14.4 kcal/mol in solvation energy. The hexamer formed by SD1/SD2 and SD2/SD2 subdomain pairings further occludes ∼4,300 Å 2 of surface area, with a total gain in solvation energy of −23.7 kcal/mol. To our knowledge, such architecture is unprecedented for bEBP family members and underscores the unique mechanism of FleQ regulation and function.
C-di-GMP Drives FleQ Oligomeric Reorganization in Solution. External signal stimuli, such as ligand binding (ATP or promoter DNA) and protein phosphorylation at the REC domain, usually trigger the switch of inactive bEBP dimers to ring-like activated hexamers (17, 19, 37) . In this regard, FleQ behavior deviates once again from canonical bEBPs, by being able to spontaneously hexamerize in solution (21) . In addition, although the N-terminal domain of FleQ shares sequence homology with canonical REC domains, it lacks both sequence conservation at the putative phosphorylation site and a cognate histidine kinase (12), making regulatory phosphorylation unlikely.
To evaluate the role of ligand binding on FleQ oligomerization in solution, we captured discrete oligomeric species through chemical cross-linking with the amine-reactive compound ethylene glycol bis-(succinimidyl succinate) (EGS). In agreement with previous results (21), wild-type full-length FleQ (Pa_FleQ   Full   ) showed a dimeric fraction as well as discrete higher-order species (mostly tetramers and hexamers), regardless of the absence or presence of ATP-γ-S (Fig. 3) . A cross-linking time-course revealed a gradual accumulation of the higher oligomeric species, suggesting an equilibrium between FleQ oligomers in solution (Fig. 3A) . Most notably, however, addition of c-di-GMP stalled FleQ oligomerization beyond a dimeric species, regardless of ATP-γ-S availability (Fig. 3B) . The striking effect of c-di-GMP on FleQ's oligomeric assembly mirrors the dinucleotide's effect on FleQ's protease sensitivity (21) , and corroborates c-di-GMP-driven quaternary structure changes inferred from the crystal structures ( Figs. 1 and 2) .
Similar cross-linking experiments using FleQ constructs lacking the REC domain, Pa_FleQ AAA and Pa_FleQ
AAA-HTH
, showed less pronounced effects (Fig. S4) . In particular, oligomerization of Pa_FleQ AAA was severely compromised, with the protein migrating mostly as a monomer, independent of nucleotide (Fig. S4A) . This result is consistent with a recent report that dimerization of the noncanonical REC domains is critical for FleQ oligomerization and function (32) . Inclusion of the C-terminal HTH domain restored insolution dimerization partially (Fig. S4B) . Addition of c-di-GMP ) including trimers and hexamers, consistent with a change in quartenary structure and our crystallographic analyses. These results mirror studies on trunctation mutants of other bEBPs, which revealed oligomerization properties and functional activities distinct from their full-length counterparts. For example, removal of the N-terminal regulatory domain of Salmonella enterica serovar Typhimurium NtrC and Aquifex aeolicus NtrC1 inhibits or promotes, respectively, the formation of activated oligomeric ring assemblies (19, 20) .
Taken together, our data indicate that c-di-GMP antagonizes different FleQ oligomeric assemblies, in accordance with our structural analyzes. The cross-linking studies not only indicate a crucial role of the REC domain for spontaneous FleQ oligomerization but also suggest that hexamer formation may be a prerequisite of c-di-GMP binding. E were designed to directly inhibit c-di-GMP binding; and two additional mutations were chosen to disrupt the SD1/SD2 (T 149 E) or SD2/SD2 (V 380 E) interfaces observed in the c-di-GMP-bound Pa_FleQ AAA-HTH structure (Fig. 4A) . The proper folding and preserved stability of all mutants introduced in the fulllength protein were verified by circular dichroism experiments of thermal denaturation (Fig. S5A) .
In the absence of c-di-GMP, higher molecular weight oligomers beyond dimers were severely disrupted only with the I 374 E mutant, consistent with our structure-based prediction (Fig. 4B) . Mutants with disrupted c-di-GMP binding pocket (R 185 E and R 334 E) retained wild-type-like oligomerization patterns, but were impaired in c-di-GMP's antagonistic effect on assembly ( Fig. 4B and Fig. S5B ). Mutations designed to disrupt the interfaces SD1/SD2 and SD2/SD2 observed in the c-di-GMPbound structure, T 149 E and V 380 E, respectively, maintained FleQ's propensity to form hexamers, rendering the protein apparently insensititve to c-di-GMP (Fig. 4B, lanes 5-6, and Fig.  S4B) . Hence, destabilization of the crystallographically observed dimer-of-trimers appears to have a positive effect on the stability of the canonical bEBP hexamer. Similar to wild-type FleQ, ATP-γ-S did not alter the oligomerization propensities of any of the mutants (Fig. S5B) .
Based on the fact that FleQ is an active ATPase that is primarily dimeric in solution, it has been proposed previously that the dimers are the catalytically active conformation (21) . As we show here, however, FleQ samples higher-order oligomeric conformations in solution, including hexameric rings (Fig. 3 and Fig. S1B) , and its AAA+ domain crystallizes in a conformation consistent with the active-state ring hexamers of canonical bEBPs (Fig. 1D) . These data prompted us to dissect the role of oligomerization on the protein's catalytic activity. In ATPase activity assays, we observed a severe reduction in the ATP hydrolysis rate with the I 374 E mutant (Fig. 4C ). Because the cross-linking indicates a defect in hexamer formation while dimerization is preserved in this mutant, these data assert the hexamer as the catalytically active conformation.
The ATPase activity data also confirm conformational coupling between the c-di-GMP-and ATP-binding pockets: disruption of the conserved R 185 and R 334 residues abolishes not only c-di-GMP binding, but also ATPase activity ( Fig. 4C and Fig. S2B ), in line with their structural role in active-site stabilization (Fig. 1C) . Mutants designed to disrupt crystallographic, c-di-GMP-mediated dimer-of-trimers, T 149 E and V 380 E, have preserved and even enhanced ATPase activity (7.5-and 1.5-fold increase over wild-type for T 149 E and V 380 E, respectively) (Fig.  4C) . Analysis of the known inhibitory effect of c-di-GMP on FleQ's ATPase activity (21) revealed that although the V 380 E mutation reduces c-di-GMP sensitivity only slightly, the high activity of the T 149 E mutant remains unaffected (Fig. 4D) . To evaluate the impact of SD1/SD2 or canonical ring interface perturbations on c-di-GMP binding, we performed ITC experiments with FleQ variants T 149 E and I 374 E, respectively. Under the same experimental conditions used for wild-type Pa_FleQ Full , ITC results with both mutants revealed a severe reduction of heat released during the titration (Fig. 4E) , indicating that disruptive mutations at both oligomeric interfaces observed in the distinct crystallographic hexamers (ring-shaped or dimer-of-trimers) (Figs. 1D and 2E ) negatively affects c-di-GMP binding.
FleQ Oligomeric Reorganization Triggered by c-di-GMP Is Compatible with Its Repressor-to-Activator Functional Transition on EPS Gene
Expression. FleQ recognizes two sites (FleQ boxes 1 and 2), separated by 34 bp, in the pelA promoter region (Fig. S6) (13) . Previous reports showed that FleQ, stabilized by FleN and ATP/ ADP, binds to both sites simultaneously, promoting a kink in the DNA and thus repressing gene expression (13) . C-di-GMP binding to FleQ relieves the DNA distortion and activates gene expression without affecting the apparent protein occupancy on DNA (13, 14) . In a mutant strain with a fleN deletion, FleQ still acts as an ATP-independent repressor of pel expression and increased c-di-GMP levels induce FleQ-mediated pel expression, albeit at a reduced level (14) . Hence, the ΔfleN genetic background offers a unique possibility to examine directly the role of FleQ's quaternary structure on pel transcriptional repression and activation. To evaluate the physiological role of the structural transition observed in vitro on transcriptional regulation via FleQ, we tested the effect of the various FleQ variants on pel operon expression in vivo.
Wild-type or mutant FleQ was expressed from a single-copy under its native promoter in a ΔfleN background. Elevated c-di-GMP levels were achieved by the coexpression of the active diguanylate cyclase YfiN/TpbB/PA1120 (38, 39) . In line with previous results, pel expression was markedly enhanced upon YfiN coexpression with wild-type FleQ, indicating c-di-GMP-dependent transcription derepression and activation (Fig. 5A) (14) . As expected, both promoter repression and YfiN effects were abolished in a fleQ deletion strain. Consistent with the structural and biochemical data, c-di-GMP binding mutants (R 185 E, N 186 A, E 330 A, and R 334 E) exhibited markedly repressed pel transcription similar to wild-type fleQ, but remained virtually unchanged upon YfiN overexpression (Fig. 5A) . The mutant T 149 E, predicted to disrupt the c-di-GMP-stablized crystallographic dimer-of-trimers, also yielded repressed pel transcription, independent of c-di-GMP. Consistent with its residual c-di-GMP sensitivity as demonstrated by the ATPase data, mutant V 380 E showed a somewhat derepressed pel transcription upon coexpression of a diguanylate cyclase (Figs. 4 and 5A) . Notably, the I 374 E mutant was characterized by constitutively active pel expression, suggesting that hexameric ring formation is required for repression of the operon (Fig. 5A) .
Taken together, the expression data in mutant genetic backgrounds corroborate the structural and biochemical results, indicating an equilibrium between ATPase-active, pel repressive hexamers, and other less-functional oligomeric species. However, ATPase activity is not required for FleQ's function as a transcriptional repressor at the pel operon. C-di-GMP appears to exert its stimulatory effect on pel expression on FleQ variants that retain their ability to form hexamers and display an intact dinucleotide binding site (e.g., wild-type and V 380 E).
Discussion
In response to specific stimuli, canonical bEBPs from the large AAA+ family of σ
54
-dependent transcription regulators couple ATP hydrolysis to promoter-RNAP initiation complex remodeling to control associated gene expression (15) . Although unusual, some bacterial activators, such as Pseudomonas putida PhhR, E. coli TyrR, Rhodobacter capsulatus HupR, and Myxococcus xanthus HsfA share similar domain architecture with bEBPs, but activate the σ 70 -RNAP holoenzyme instead of the σ 54 -associated transcriptional machinery (40) (41) (42) . P. aeruginosa FleQ combines both canonical bEBP σ
-and atypical σ 70 -dependent transcriptional mechanisms to inversely control flagellar motility and EPS production, respectively (13, 14, 21) . Significantly, FleQ is also regulated by the bacterial second messenger dinucleotide, c-di-GMP (14) . To gain molecular insight into the mechanism of c-di-GMP-dependent regulation of P. aeruginosa EPS gene expression by FleQ, we determined structures of its AAA+ domain in the apo-state and bound to ADP, ATP-γ-S, and c-di-GMP. Analyses of these structures, combined with in vitro and in vivo functional studies, revealed that P. aeruginosa FleQ undergoes a major conformational change upon c-di-GMP binding, concomitant with oligomeric rearrangement.
On one hand, the results presented here indicate a hexameric FleQ as the functional pel transcription repressor and as the target of c-di-GMP, because destablilization of the canonical AAA+ ring interfaces reduces c-di-GMP binding to FleQ (mutant I 374 E) (Figs. 4 and 5 and Fig. S1C ). On the other hand, perturbations at the unique interfaces that support the crystallographic, c-di-GMP-bound FleQ dimer-of-trimers (e.g., mutants T 149 E and V 380 E) not only render the protein variants insensitive to c-di-GMP, but also stabilize highly ATPase-active FleQ oligomers (Fig. 4) . This finding may suggest that different FleQ oligomers with distinct properties exist in equilibrium (Fig. 4) .
In light of our results and previous studies on the regulation of EPS gene expression, we propose that canonical bEBP ring-like FleQ hexamers (Fig. 1D and Fig. S1B ) bind both boxes 1 and 2 at the pelA promoter, which inhibits transcription initiation (Fig.  5B) . Apparently, FleQ's function as a pel repressor in the absence of the cofactor FleN does not require its ATPase activity, but depends on the protein's ability to form higher-order oligomers, in particular hexameric rings (Figs. 4 and 5) . The hexamerto-DNA interaction model is also compatible with the promoter bending observed previously (Fig. S6) (13) . The current hypothesis is that association of ATP-bound FleN to the FleQ:DNA complex is necessary to increase DNA curvature in vitro and that the FleQFleN interaction cooperatively enhances c-di-GMP binding (13, 21) , consistent with full activation of FleQ-c-di-GMP-mediated pel transcription requiring FleN (14) . In analogy, the repression of σ 70 -dependent tyrR expression by the atypical bEBP TyrR from E. coli occurs via binding of tyrosine-stabilized hexamers to two adjacent sites at the promoter DNA (14, 43-46) , suggesting that the mechanism described here might be a recurrent form of transcriptional repression by atypical bEBPs.
In the presence of c-di-GMP, FleQ undergoes conformational changes and alters its quaternary structure (Figs. 2 and 3) , which may decrease affinity for at least some promoter interaction sites, thus relieving DNA bending and activating gene transcription (Fig. 5 and Fig. S6 ) (14) . bEBPs interact with σ 54 via two loops, L1 and L2. However, in our structures, these loops are accessible in the c-di-GMP-stabilized oligomer and not subject to conformational changes (Fig. 2C) , suggesting a mode of transcriptional activation different from canonical bEBPs (18) . The lack of conservation or absence of σ 54 -interacting loops in other σ 70 -dependent bEBP, such as E. coli TyrR and P. putida PhhR, respectively, argues further against their role in the direct activation of pel expression (40, 46) .
Our data explain the molecular mechanism underlying c-di-GMP regulation of FleQ's functions as repressor and activator of pel expression, which likely depends on σ 70 and is only moderately affected by the cofactor ATPase FleN. Future studies will focus on the roles of the N-terminal regulatory domains upstream of the AAA+ core and accessory proteins such as FleN in the context of FleQ's oligomeric states, and in particular on the regulation of flagellar gene regulation. The latter process requires FleQ's ATPase activity and σ 54 , distinct from the mechanism described here, and presumably mirrors those of canonical bEBPs. How σ 54 -and ATPase-dependent processes are coordinated with σ 70 -dependent but ATPase-independent regulation at different promoters remains an open question.
Materials and Methods
Recombinant DNA Techniques. DNA manipulations were carried out using standard molecular biology techniques. For protein expression and purification, the ORFs of full-length and truncated FleQ variants were PCRamplified from P. aeuruginosa PA14 genomic DNA and cloned in-frame into a modified pET28a expression plasmid (Novagen). Expression yields recombinant proteins with an N-terminal hexahistidine-SUMO moiety that can be liberated by incubation with yeast Ulp1 protease. FleQ point mutants were generated using QuikChange site-directed mutagenesis kit (Agilent), following the manufacturer's instructions. Successful mutagenesis was confirmed by DNA sequencing. Protein Expression and Purification. Native and selenomethionine-derivatized proteins were overexpressed in E. coli BL21 (DE3) (Novagen) or T7 Crystal Express (New England Biolabs) cells, respectively. For the expression of native proteins, cells were grown at 37°C in lysogeny broth (LB) medium supplemented with 50 μg/mL kanamycin. At a cell density corresponding to an absorbance of 0.6 at 600 nm (OD 600 ), the temperature was reduced to 20°C and protein production was induced with 1 mM IPTG. Selenomethionine-derivatized proteins were produced in cells grown in M9 minimal medium supplemented with 50 μg/mL kanamycin, 1 μg/mL thiamine, 1 μg/mL biotin, 0.4% glucose, and 40 μg/mL of each of the 20 amino acids with selenomethionine substituting for methionine. Protein expression was induced at an OD 600 of 0.4. After overnight expression, the cells were harvested by centrifugation, resuspended in resuspension buffer (25 mM Tris·HCl pH 8.0 and 300 mM NaCl) and lysed by sonication. Cell debris was removed by centrifugation and the cleared lysates were loaded onto TALON metal affinity resin (Clontech). The matrix was washed with 20 column volumes (CV) of resuspension buffer, followed by elution of bound proteins with elution buffer (25 mM Tris·HCl pH 8.0, 300 mM NaCl, and 500 mM imidazole). The eluted fractions were buffer-exchanged into resuspension buffer and incubated with Ulp1 protease at 4°C overnight. Cleaved His 6 -SUMO tags and uncut protein was removed via TALON metal affinity chromatography, and the cleaved target proteins were recovered in the flow-through. Purified protein was subjected to size exclusion chromatography on a HiLoad 16/600 Superdex 75 column (GE Healthcare) in gelfiltration buffer (25 mM Tris·HCl pH 8.0 and 300 mM NaCl). Purity of the proteins was analyzed by SDS/PAGE. Circular Dichroism Spectroscopy. Circular dichroism measurements were performed using a J-720 (JASCO) spectroscope. Initial spectra of Pa_FleQ AAA-HTH -c-di-GMP). All diffraction images were processed using the software package XDS (47) . The apo-FleQ AAA structure was solved using SAD with iodine as the anomalous scatterer, collected on crystals that were soaked in mother liquor supplemented with 500 mM NaI and 10% (vol/vol) ethylene glycol (48, 49) . Initial phases were extended to 1.8 Å resolution from a native dataset using the PHENIX program package (50) . ADP-and ATP-γ-Sbound Pa_FleQ AAA were solved by molecular replacement in PHENIX, with the apo structure as the starting model. The structure of Pa_FleQ AAA-HTH -c-di-GMP was solved by SAD phasing with data collected on crystals grown from selenomethionine-derivatized protein. The heavy atom positions were determined with SHELX (51) and automatic building was conducted in PHENIX. For all constructs, iterative model building and refinement in COOT (52) and PHENIX yielded the final structural models.
Electron Microscopy. Pa_FleQ Full (50 μM) was incubated with 100 μM ADP, 200 μM sodium vanadate, and 500 μM MgCl 2 . Following a 30-min incubation on ice, the protein was gel-filtered against an ADP-vanadate-containing buffer [20 mM Tris·HCl pH 8.0, 100 mM NaCl, 2.5% (wt/vol) xylitol, 100 μM ADP, 200 μM sodium vanadate, and 500 μM MgCl 2 ] on a Superdex 200 10/300 GL size exclusion column (GE Healthcare). Five-microliter drops of protein at concentrations between 0.005 and 0.1 mg/mL were placed directly on glow-discharged carbon-coated grids (EMS) for 1 min. The grids were then blot-dried on filter paper and negatively stained with 2% (wt/vol) uranyl acetate in water. Specimens were examined on an FEI Tecnai T12 BioTWIN LaB6 electron microscope operating at 120 kV at nominal magnifications of 49,000 and 1-3 μm defocus.
Images were recorded on a Gatan Ultrascan 4000 CCD camera. The contrast transfer function parameters were assessed using CTFFIND3 (53) and the phase flipping was done in SPIDER (54) . Single particles were boxed manually and a single-particle stack was generated in EMAN2 (4,856 particles, 170 × 170-pixel box, 2.2 Å per pixel) (55) . Normalization, centering, multireference alignment, multistatistical analysis, classification (∼40 particles per class), and rotational autocorrelation function calculation were done in IMAGIC-4D (Image Science Software).
Isothermal Titration Calorimetry. Apparent dissociation constants (K d ) and stoichiometry of interaction (n) were measured by ITC using a VP-ITC calorimeter (Microcal). Calorimetric titrations of c-di-GMP (700 μM in the syringe; 7-μL injections) and wild-type or mutant Pa_FleQ Full (30 μM in the cuvette)
were carried out at 25°C in assay buffer (25 mM Tris·HCl pH 8.0, 300 mM NaCl, 5 mM MgCl 2 ) with 150-s spacing between injections. ITC data were analyzed by integrating heat effects normalized to the amount of injected protein and curve-fitting based on a single-site binding model using the MicroCal Origin 7.0 software. Heat changes during ITC titrations likely combine contributions from c-di-GMP binding and accompanied changes in intra-and intermolecular protein interfaces. Heat from the dilution of c-di-GMP alone was subtracted before data analysis and the first injection was omitted from data processing.
In-Solution Chemical Cross-Linking. For oligomeric state detection, protein in cross-linking buffer (25 mM Hepes pH 8.0 and 300 mM NaCl) was incubated with EGS at room temperature. Protein and cross-linker concentrations and incubation times are specified in the respective figure legends. Cross-linking reactions were quenched by adding 50 mM Tris·HCl pH 8.0, followed by incubation at 97°C for 10 min in standard SDS/PAGE sample buffer. Oligomer formation was analyzed by SDS/PAGE.
ATPase Activity Assay. ATPase activity of wild-type and mutant Pa_FleQ Full was measured with the EnzChek Phosphate Assay kit (Life Technologies) (56) . Assays were performed in triplicates in a 96-well plate according to the manufacturer's instructions. Briefly, ATPase reactions (200 μL; 1 μM enzyme) were carried in ATPase buffer (25 mM Hepes pH 8.0, 300 mM NaCl buffer, 1 mM DTT, 10 mM KCl, 1 mM MgCl 2 , and 1 mM ATP). The reactions were monitored at 1-min intervals at 360 nm in a microplate reader.
P. aeruginosa Strain Construction, RNA Isolation, and Real-Time Quantitative PCR. P. aeruginosa strains PAO1ΔfleQΔfleN or strains containing different mutations in the fleQ gene were routinely grown in LB medium at 37°C. Mutations in the fleQ gene were generated by an overlapping PCR procedure. Briefly, PCR fragments containing the mutated fleQ gene and flanking genomic DNA were cloned into pEX19Gm or miniCTX2. fleQ WT and fleQ R334E were cloned into miniCTX2. fleQ I374E , fleQ V256E , fleQ R185E , fleQ V380E , and fleQ T149E were cloned into pEX19Gm. The resulting plasmids were then used to transform E. coli S17-1 strain and mobilized into the PAO1ΔfleQΔfleN strain. MiniCTX2 constructions allow the introduction of fleQ WT and fleQ R334E at the attB site on the P. aeruginosa chromosome, whereas pEX19Gm constructions allow the introduction of fleQ variant alleles at the fleQ native location. Plasmids pJN1120 (expressing YfiN/TpbB/ PA1120 diguanylate cyclase) and pJN105 (empty vector) were electroporated into the constructed strains (14, 57, 58) . Cell growth, RNA extraction, and RT-PCR were performed essentially as previously described (13, 14, 59) . The pelA-forward (CCT TCA GCC ATC CGT TCT TCT) and pelA-reverse (TCG CGT ACG AAG TCG ACC TT) primers were used. Genomic DNA was used as a standard and transcript levels of all genes were normalized to total cDNA. Data presented are at least the average of two biological replicates. Error bars represent the SD between samples.
